In prostate cancer, PTHrP expression varies depending on the cancer stage, with expression detected in 33% of benign prostate hyperplasias, 87% of well-differentiated tumors and 100% of poorly differentiated and metastatic tumors (154). The gene discussed is PTHLH; the disease is prostate cancer.